FrancophonIA/ELRC3.0 huggingface dataset:
English: In addition, the company that makes Kivexa will provide educational material for all doctors who are expected to prescribe this medicine to increase awareness of the risk of hypersensitivity reactions and to provide guidance on how to manage it.
Croatian: Nadalje, proizvođač lijeka Kivexa dostavit će edukacijske materijale svim liječnicima za koje se očekuje da će propisivati ovaj lijek s ciljem povećavanja svijesti o riziku od reakcija preosjetljivosti i pružanja smjernica za upravljanje istim.
English: Kivexa abacavir and lamivudine
Croatian: Kivexa abakavir i lamivudin
English: Both active substances in Kivexa, abacavir and lamivudine, are nucleoside reverse transcriptase inhibitors (NRTIs).
Croatian: Obje djelatne tvari lijeka Kivexa, abakavir i lamivudin, nukleozidni su inhibitori reverzne transkriptaze (NRTI-ovi).
English: Patients who need to adjust the dose of abacavir or lamivudine should take the medicines separately.
Croatian: Bolesnici kojima je potrebno prilagođavanje doze abakavira ili lamivudina trebaju uzimati lijekove zasebno.
English: Patients with this gene are at an increased risk of having an allergic reaction to abacavir, so they should not take Kivexa.
Croatian: Bolesnici s tim genom izloženi su povećanom riziku od alergijske reakcije na abakavir pa ne bi smjeli uzimati lijek Kivexa.
English: Kivexa should be prescribed by a doctor who has experience in the management of HIV infection.
Croatian: Terapiju lijekom Kivexa mora propisati liječnik s iskustvom u liječenju infekcije HIV-om.
English: What is Kivexa?
Croatian: Što je Kivexa?
English: What is the risk associated with Kivexa?
Croatian: Koji su rizici povezani s lijekom Kivexa?
English: The combination tablet taken once a day was also as effective as the medicines taken separately twice a day in reducing viral loads over 24 weeks of treatment.
Croatian: Kombinirana tableta uzimana jednom na dan bila je podjednako djelotvorna u smanjivanju virusnog opterećenja tijekom razdoblja terapije od 24 tjedna kao i lijekovi uzimani zasebno dvaput na dan.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Kivexa, including the appropriate precautions to be followed by healthcare professionals and patients.
Croatian: Na temelju tog plana, u sažetku opisa svojstava lijeka kao i u uputi o lijeku za lijek Kivexa nalaze se sigurnosne informacije, uključujući odgovarajuće mjere opreza kojih se zdravstveni djelatnici i bolesnici trebaju pridržavati.
English: Why has Kivexa been approved?
Croatian: Zašto je lijek Kivexa odobren?
English: The CHMP decided that Kivexa's benefits are greater than its risks and recommended that it be given marketing authorisation.
Croatian: CHMP je odlučio da koristi od lijeka Kivexa nadmašuju s njim povezane rizike te je preporučio izdavanje odobrenja za stavljanje lijeka u promet.
English: Kivexa, taken in combination with at least one other HIV medicine, reduces the amount of HIV in the blood and keeps it at a low level.
Croatian: Kad se uzima u kombinaciji s najmanje još jednim drugim lijekom protiv HIV-a, Kivexa smanjuje koncentraciju HIV-a u krvi i održava je niskom.
English: Kivexa is used in combination with at least one other antiviral medicine to treat adults and children weighing at least 25 kg who are infected with human immunodeficiency virus (HIV), the virus that causes acquired immune deficiency syndrome (AIDS).
Croatian: Lijek Kivexa primjenjuje se u kombinaciji s najmanje još jednim protuvirusnim lijekom za liječenje infekcije virusom humane imunodeficijencije (HIV), virusa koji uzrokuje sindrom stečene imunodeficijencije (AIDS), u odraslih i djece tjelesne težine od barem 25 kg.
English: What benefit has Kivexa shown during the studies?
Croatian: Koje su koristi lijeka Kivexa utvrđene u ispitivanjima?
English: How does Kivexa work?
Croatian: Kako djeluje Kivexa?
English: What is Kivexa used for?
Croatian: Za što se Kivexa koristi?
English: For the full list of all side effects reported with Kivexa, see the package leaflet.
Croatian: Potpuni popis nuspojava zabilježenih pri primjeni lijeka Kivexa potražite u uputi o lijeku.
English: How is Kivexa used?
Croatian: Kako se Kivexa koristi?
English: How has Kivexa been studied?
Croatian: Kako je lijek Kivexa ispitivan?
English: Initiation pack: 2 cartridges
Croatian: Pakiranje za početak liječenja: 2 uloška
English: Initiation pack: 6 pre-filled syringes of 8.8 µg + 6 pre-filled syringes of 22 µg
Croatian: Pakiranje za početak liječenja: 6 napunjenih štrcaljki 8,8 µg + i 6 napunjenih štrcaljki 22 µg
English: Initiation pack: 6 pre-filled pens of 8.8 µg + 6 prefilled pens of 22 µg
Croatian: Pakiranje za početak liječenja: 6 napunjenih brizgalica 8,8 µg + i 6 napunjenih brizgalica 22 µg
English: 2 October 2013
Croatian: 2. listopada 2013.
English: International non-proprietary name (INN): altrenogest
Croatian: Međunarodni nezaštićeni naziv (INN): altrenogest
English: France is the reference Member State and Austria, Germany, Hungary, the Netherlands, Poland, Romania, Spain and the United Kingdom are concerned Member States.
Croatian: Referentna država članica je Francuska, a Austrija, Njemačka, Mađarska, Nizozemska, Poljska, Rumunjska, Španjolska i Ujedinjena Kraljevina su države članice sudionice u postupku.
English: The Committee appointed Dr C. Ibrahim as rapporteur and Dr M. Holzhauser-Alberti as co-rapporteur.
Croatian: Povjerenstvo je imenovalo Dr. C. Ibrahima kao izvjestitelja i Dr. M. Holzhauser-Albertia kao pomoćnog izvjestitelja.
English: Article 33(4) of Directive 2001/82/EC, as amended
Croatian: Članak 33. (4) Direktive 2001/82/EZ s izmjenama
English: The opinion was converted into a Decision by the European Commission on 2 October 2013.
Croatian: Zaključno mišljenje promijenjeno je u odluku Europske komisije dana 2. listopada 2013.
English: The decentralised procedure started on 7 October 2011.
Croatian: Decentralizirani postupak započet je dana 7. listopada 2011. godine.
English: Potential serious risks were identified during the decentralised procedure by Germany regarding the environmental safety of the product.
Croatian: Tijekom decentraliziranog postupka, Njemačka je identificirala moguće ozbiljne rizike u pogledu sigurnosti za okoliš.
English: Day 60 of the CMD(v) procedure was on 14 February 2013, and since the Member States concerned failed to reach an agreement regarding the product the procedure was referred to the CVMP.
Croatian: Dana 14. veljače 2013. bio je 60. dan postupka CMD(v)-a, a s obzirom da države članice sudionice u postupku nisu uspjele postići dogovor u svezi s proizvodom, postupak je upućen CVMP-u.
English: The referral procedure started on 6 March 2013.
Croatian: Postupak upućivanja započet je dana 6. ožujka 2013. godine.
English: On 1 March 2013, the reference Member State, France, notified the European Medicines Agency that the CMD(v) had failed to reach an agreement regarding the product and referred the matter to the CVMP pursuant to Article 33(4) of Directive 2001/82/EC.
Croatian: Dana 1. ožujka 2013. godine, referentna država članica, Francuska, obavijestila je Europsku agenciju za lijekove da CMD(v) nije postigao sporazum u svezi sa VMP-om te da je uputio predmet CVMP-u u skladu sa člankom 33.(4) Direktive 2001/82/EZ.
English: This is a generic application according to Article 13(1) Directive 2001/82/EC, as amended, referring to the reference product Regumate oily solution 4 mg/ml.
Croatian: Ovo je generički zahtjev u skladu sa člankom 13. stavkom 1. Direktive 2001/82/EZ i njezinih izmjena te se odnosi na referentni lijek Regumate uljnu otopinu 4 mg/ml.
English: Having considered all the overall submitted data in writing the CVMP concluded that there is no product specific concern identified for the Suifertil 4 mg/ml Oral Solution for Pigs that is different from the other, already authorised, altrenogest containing veterinary medicinal products.
Croatian: Imajući na umu ukupne predane pismene podatke, CVMP je zaključio da nije identificirana specifična zabrinutost povezana s proizvodom za Suifertil 4 mg/ml oralnu otopinu za svinje koja je različita od drugih veterinarsko-medicinskih proizvoda koji sadrže altrenogest.
English: Suifertil 4 mg/ml Oral Solution for Pigs contains altrenogest as active ingredient and is intended for use in pigs for the synchronisation of oestrous in sexually mature gilts.
Croatian: Suifertil 4 mg/ml, oralna otopina za svinje sadrži altrenogest kao djelatnu tvar i predviđena je za uporabu u svinja za sinkronizaciju estrusa u spolno zrelih nazimica.
English: Therefore, the Committee adopted by consensus a positive opinion on 18 July 2013 recommending the granting of a marketing authorisation for Suifertil 4 mg/ml Oral Solution for Pigs and associated names.
Croatian: Stoga je Povjerenstvo konsenzusom usvojilo pozitivno mišljenje dana 18. srpnja 2013. godine, te je preporučilo izdavanje odobrenja za stavljanje u promet Suifertil 4 mg/ml oralne otopine za svinje i povezanih naziva.
English: The applicant, aniMedica GmbH, submitted an application for a decentralised procedure for Suifertil 4 mg/ml Oral Solution for Pigs and associated names.
Croatian: Podnositelj zahtjeva, aniMedica GmbH, zatražio je decentralizirani postupak za Suifertil 4 mg/ml oralnu otopinu za svinje i povezane nazive.
English: Written explanations were provided by the applicant on 21 May 2013.
Croatian: Dana 21. svibnja 2013. godine podnositelj zahtjeva dostavio je pisana pojašnjenja.
English: The list of product names concerned is given in Annex I. The scientific conclusions are provided in Annex II, together with the Summary of Product Characteristics and package leaflet in Annex III.
Croatian: Znanstveni zaključci navedeni su u Dodatku II. zajedno sa Sažetkom opisa svojstava VMP-a i uputama o VMP-u u Dodatku III.
English: On day 210, these issues remained unsolved and therefore a referral under Article 33(1) of Directive 2001/82/EC to the Coordination group for Mutual recognition and Decentralised procedures (veterinary) (CMD(v)) was started on 17 December 2012.
Croatian: Koordinacijska grupa za postupak međusobnog priznavanja i decentralizirani postupak za veterinarsko-medicinske lijekove (CMD(v)) započela postupak upućivanja sukladno članku 33. (1) Direktive 2001/82/EZ.
English: Opinion following an Article 33(4)0F referral for Suifertil 4 mg/ml Oral Solution for Pigs and associated names
Croatian: Mišljenje nakon postupka upućivanja sukladno članku za Suifertil 4 mg/ml oralnu otopinu za svinje i povezane nazive
English: Ampoule (LDPE) 2.4 ml (100 mg/ml) 56 Ampoules + 1 Nebuliser Handset
Croatian: U dišne putove Ampula (LDPE) 2,4 ml (100 mg/ml) 56 ampula + 1 ručni atomizator
English: 240 mg Nebuliser solution Inhalation use
Croatian: 240 mg Otopina za atomizator.
English: Initiation pack: 49 tablets (42 x 15 mg + 7 x 20 mg)
Croatian: Pakiranje za početno liječenje: 49 tableta (42 x 15 mg + 7 x 20 mg)
English: Film-coated tablet Oral use
Croatian: Filmom obložena tableta Kroz usta blister (PP/Al)
English: 100 (10 x 10 x 1) tablets (unitdose) (multipack)
Croatian: 10 mg Filmom obložena tableta Kroz usta blister (PVC/PVDC/Al) 100 x 1 tableta (jedinična doza)
English: • Then wait at least 30 minutes before eating any food.
Croatian: • Zatim pričekajte najmanje 30 minuta prije nego uzmete hranu.
English: This is a long-term treatment, possibly lasting for months or years.
Croatian: To je dugotrajno liječenje koje bi moglo trajati mjesecima ili godinama.
English: Frequency not known (cannot be estimated from the available data).
Croatian: Učestalost nije poznata (ne može se procijeniti iz dostupnih podataka).
English: Adjustment steps (every 3-6 months)
Croatian: Koraci u prilagodbi doze (svakih 3-6 mjeseci)
English: and Once (1x)
Croatian: i jednom (1x)
English: • If you get a severe rash, or difficulty breathing and dizziness or swelling mainly of the face and throat (signs of severe allergic reaction),
Croatian: Vam se pojača žutilo kože ili očiju i imate tamnu mokraću (znakovi jetrenih problema),
English: 9/l) (see section 4.5).
Croatian: 9/l) (vidjeti dio 4.5).
English: EXJADE is not recommended for children aged under 2 years.
Croatian: EXJADE se ne preporučuje za djecu mlađu od 2 godine.
English: • Drink everything in the glass.
Croatian: • Popijte cijeli sadržaj čaše.
English: Urgent medical treatment may be necessary.
Croatian: Možda će biti potrebna hitna medicinska skrb.
English: Cannot be sold separately.
Croatian: Ne smije se prodavati zasebno.
English: The safety and efficacy of EXJADE in children from birth to 23 months of age have not been established.
Croatian: Sigurnost i djelotvornost lijeka EXJADE u djece u dobi od rođenja do 23 mjeseca nisu ustanovljene.
English: Other medicines and EXJADE
Croatian: Drugi lijekovi i EXJADE
English: 1, toxic epidermal necrolysis (TEN)
Croatian: 1, toksična epidermalna nekroliza (TEN)
English: • Serum creatinine remains significantly elevated and
Croatian: • serumski kreatinin ostaje značajno povišen i
English: • If you experience partial loss of vision,
Croatian: • Ako imate djelomičan gubitak vida,
English: The liquid in the glass will look cloudy.
Croatian: Tekućina u čaši izgledat će mutna.
English: Then add a little water or juice to what is left in the glass, swirl the liquid around and drink that too.
Croatian: Zatim dodajte još malo vode ili soka talogu preostalom u čaši, promućkajte tekućinu i to također popijte.
English: If you stop taking it, the excess iron will no longer be removed from your body (see also above section “How long to take EXJADE”).
Croatian: Ako ga prestanete uzimati, višak željeza više se neće uklanjati iz Vašeg tijela (pogledajte također dio „Koliko dugo uzimati EXJADE”).
English: • The recommended doses and the rules for starting treatment
Croatian: • preporučene doze i pravila za početak liječenja
English: Liver iron concentration (LIC)*
Croatian: Koncentracija željeza u jetri (LIC)*
English: (signs of severe skin reactions),
Croatian: (znakovi teške alergijske reakcije),
English: The educational programme is aimed to inform healthcare professionals and patients to minimise the risks of:
Croatian: Cilj edukacijskog programa je informiranje zdravstvenih radnika i bolesnika o minimalizaciji rizika u slučaju:
English: If you have questions about how long to take EXJADE, talk to your doctor.
Croatian: Ako imate pitanja o tome koliko dugo uzimati EXJADE, obratite se svom liječniku.
English: • Proteinuria (test should be performed prior to therapy and monthly thereafter)
Croatian: • proteinurija (pretraga se treba provesti prije terapije i mjesečno poslije toga)
English: • Abnormal level of acid in blood
Croatian: • Nenormalna razina kiseline u krvi
English: • Depending on how you respond to treatment, your doctor may later adjust your treatment to a higher or lower dose.
Croatian: • Ovisno o Vašem odgovoru na liječenje, liječnik kasnije može prilagoditi liječenje višom ili nižom dozom.
English: If you miss a dose, take it as soon as you remember on that day.
Croatian: Ako ste propustili uzeti dozu, uzmite ju istog dana čim se sjetite.
English: If such reactions occur, EXJADE should be discontinued and appropriate medical intervention instituted.
Croatian: Ako nastupe takve reakcije, primjena lijeka EXJADE se treba prekinuti i poduzeti odgovarajuće medicinske intervencije.
English: The tablets must not be chewed or swallowed whole (see also section 6.2).
Croatian: Tablete se ne smiju žvakati niti gutati cijele (također vidjeti dio 6.2).
English: • Stir until the tablet(s) dissolve completely.
Croatian: • Miješajte dok se tableta(e) potpuno ne otopi.
English: Date of first authorisation: 28 August 2006 Date of latest renewal: 18 April 2016
Croatian: Datum posljednje obnove odobrenja: 18. travnja 2016.
English: Elderly patients (≥65 years of age)
Croatian: Stariji bolesnici (≥65 godina starosti)
English: Do not take EXJADE - if you are allergic to deferasirox or any of the other ingredients of this medicine (listed in section 6).
Croatian: Nemojte uzimati EXJADE - ako ste alergični na deferasiroks ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.).
English: Maximum dose
Croatian: Maksimalna doza
English: What EXJADE is and what it is used for What you need to know before you take EXJADE How to take EXJADE
Croatian: Što je EXJADE i za što se koristi Što morate znati prije nego počnete uzimati EXJADE Kako uzimati EXJADE
English: Show the doctor the pack of granules.
Croatian: Pokažite liječniku pakiranje granula.
English: The safety profile was consistent with previous studies in adult MDS patients.
Croatian: Sigurnosni profil je u skladu s prethodnim ispitivanjima u odraslih bolesnika s MDS-om.
English: Since dosing is individually adjusted according to response this is not expected to have clinical consequences.
Croatian: Budući da se doziranje individualno prilagođava u skladu s odgovorom, ne očekuje se da bi to moglo imati kliničke posljedice.
English: *LLN: lower limit of the normal range **ULN: upper limit of the normal range
Croatian: *DGN: donja granica normalnog raspona **GGN: gornja granica normalnog raspona
English: Take this medicine on an empty stomach.
Croatian: Lijek uzimati na prazan želudac.
English: Metabolic acidosis
Croatian: metabolička acidoza
English: The Guide for healthcare professionals shall contain the following key elements:
Croatian: Vodič za zdravstvene radnike mora sadržavati sljedeće ključne elemente:
English: Do not take a double dose on the next day to make up for the forgotten granules.
Croatian: Sljedećeg dana nemojte uzeti dvostruku dozu kako biste nadoknadili zaboravljene granule.
English: Show the doctor the pack of tablets.
Croatian: Pokažite liječniku pakiranje tableta.
English: If this applies to you, tell your doctor before taking EXJADE.
Croatian: Ako se to odnosi na Vas, obavijestite svog liječnika prije nego počnete uzimati EXJADE.
English: Disperse tablets in water or fruit juice before swallowing.
Croatian: Tablete otopiti u vodi ili voćnom soku prije gutanja.
English: If you feel dizzy after taking EXJADE, do not drive or operate any tools or machines until you are feeling normal again.
Croatian: Ako nakon uzimanja lijeka EXJADE osjetite omaglicu, nemojte upravljati vozilima niti raditi s alatima ili strojevima sve dok se ponovno ne počnete osjećati normalno.
English: Prior to launch of deferasirox film-coated tablets, healthcare professionals will receive introductory notification letters as follows:
Croatian: Prije stavljanja deferasiroks filmom obloženih tableta u promet, zdravstveni radnici će primiti uvodnu obavijest kako slijedi:
English: What EXJADE is and what it is used for
Croatian: Što je EXJADE i za što se koristi
English: Do not stop taking EXJADE unless your doctor tells you to.
Croatian: Ne prekidajte uzimanje lijeka EXJADE, osim ako Vam to ne kaže liječnik.
English: The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and and any subsequent updates published on the European medicines web-portal.
Croatian: Zahtjevi za podnošenje periodičkih izvješća o neškodljivosti za ovaj lijek definirani su u referentnom popisu datuma EU (EURD popis) predviđenom člankom 107.c stavkom 7. Direktive 2001/83/EZ i svim sljedećim ažuriranim verzijama objavljenima na europskom internetskom portalu za lijekove.
English: • If you experience severe upper stomach pain (pancreatitis), stop taking this medicine and tell your doctor straight away.
Croatian: • Ako osjetite jaku bol u gornjem dijelu trbuha (pankreatitis), prestanite uzimati ovaj lijek i odmah obavijestite svog liječnika.
English: • Take EXJADE once a day, every day, at about the same time each day with some water.
Croatian: • EXJADE uzimajte jednom na dan, svaki dan, približno u isto vrijeme svakoga dana uz malo vode.
English: • Change in the colour of the skin
Croatian: • Promjena boje kože
English: • Tear in stomach or intestine wall that can be painful and cause nausea
Croatian: • Probijanje stijenke želuca ili crijeva koje može biti bolno i uzrokovati mučninu
English: Your doctor will take these tests into consideration when deciding on the dose of EXJADE most suitable for you and will also use these tests to decide when you should stop taking EXJADE.
Croatian: Liječnik će uzeti u obzir nalaze tih pretraga prilikom odlučivanja o najprikladnijoj dozi lijeka EXJADE za Vas, a na temelju tih pretraga će odlučiti i kada morate prekinuti uzimanje lijeka EXJADE.
English: Your doctor will regularly monitor your condition to check that the treatment is having the desired effect (see also section 2: “Monitoring your EXJADE treatment”).
Croatian: Vaše stanje kako bi provjerio ima li liječenje željeni učinak (pogledajte također dio 2: „Praćenje liječenja lijekom EXJADE“).
English: • Take EXJADE once a day, every day, at about the same time each day.
Croatian: • EXJADE uzimajte jednom na dan, svaki dan, približno u isto vrijeme svakoga dana.
English: At these same doses the ratios of iron excretion: iron intake were 1.02 (indicating net iron balance) and 1.67 (indicating net iron removal), respectively.
Croatian: Pri istim dozama omjeri izlučenog željeza: unesenog željeza bili su 1,02 (ukazuje na neto ravnotežu željeza) i 1,67 (ukazuje na neto uklanjanje željeza).
English: If you take more EXJADE than you should
Croatian: Ako uzmete više lijeka EXJADE nego što ste trebali
English: What EXJADE looks like and contents of the pack
Croatian: Kako EXJADE izgleda i sadržaj pakiranja
English: “NVR” on the other.
Croatian: „NVR“.
English: What EXJADE looks like and contents of the pack EXJADE granules are supplied as white to almost white granules in sachets.
Croatian: Kako EXJADE izgleda i sadržaj pakiranja EXJADE granule se isporučuju u obliku bijelih do gotovo bijelih granula u vrećicama.
English: Do not swallow the tablets whole.
Croatian: Tablete nemojte gutati cijele.
English: • Non-compliance of the posology and biological monitoring
Croatian: • nepridržavanja doziranja i biološkog praćenja
English: If you are currently using an oral contraceptive or using a patch contraceptive to prevent pregnancy, you should use an additional or different type of contraception (e.g. condom), as EXJADE may reduce the effectiveness of oral and patch contraceptives.
Croatian: Ako trenutno uzimate oralne kontraceptive ili koristite kontraceptive u obliku flastera radi sprječavanja trudnoće, morate koristiti dodatnu ili drugačiju vrstu kontracepcije (npr. prezervativ), budući da EXJADE može smanjiti učinkovitost oralnih kontraceptiva ili kontraceptiva u obliku flastera.
English: The mean elimination half-life (t1/2) ranged from 8 to 16 hours.
Croatian: Srednja vrijednost poluvijeka eliminacije (t1/2) kretala se u rasponu od 8 do 16 sati.
English: Your doctor may require you to undergo a kidney biopsy, if he/she suspects significant kidney damage.
Croatian: Vaš liječnik može zatražiti da Vam se napravi biopsija bubrega ukoliko sumnja na značajno oštećenje bubrega.
English: Increase
Croatian: Povećanje
English: Do not chew, break or crush the tablets.
Croatian: Tablete nemojte žvakati, lomiti ili drobiti.
English: These will monitor the amount of iron in your body (blood level of ferritin) to see how well EXJADE is working.
Croatian: Njima će se pratiti količina željeza u Vašem tijelu (razina feritina u krvi) da se vidi kako dobro EXJADE djeluje.
English: Continue taking EXJADE every day for as long as your doctor tells you.
Croatian: EXJADE uzimajte svakog dana, onoliko dugo koliko Vam je rekao liječnik.
English: • Pharmacists - a detailed letter explaining the switch between formulations
Croatian: • Ljekarnici - detaljan dopis u kojem je objašnjen prelazak s jedne na drugu formulaciju lijeka
English: The overall exposure of adolescents (12 to ≤17 years) and children (2 to <12 years) to deferasirox after single and multiple doses was lower than that in adult patients.
Croatian: Ukupna izloženost deferasiroksu adolescenata (12 do ≤17 godina) i djece (2 do <12 godina) nakon jednokratne i višestrukih doza bila je niža od one u odraslih bolesnika.